Biotech | February 07, 2022
Lay Sciences launch ImmynlgY, an oral antibody to neutralize Covid-19
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
